Skip to main content
Caplight Logo









OrganTech Inc.

OrganTech Inc.

Private
TokyoHealthcare & Life Scienceshttps://www.organ-tech.jp/

Last Round

Series D

Jun 3, 2026

Est. Valuation

$20.79M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

OrganTech Inc. is a biotechnology company that specializes in regenerative medicine, focusing on the development of bio-hybrid implants, hair follicle regeneration, and three-dimensional artificial skin technologies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

regenerative medicinetissue engineeringorgan regenerationbioengineeringhair regenerationbio-hybrid toothstem cell therapylab-grown organsbiotechartificial skinorgan germ methodbiotech startupregenerative therapyclinical trialsmedical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OrganTech Inc. Comparables

Compare OrganTech Inc. with similar companies based on industry and business-model similarity.

OrganTech Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
0913693 B.C. Ltd.
77%
Epibiotech Co., Ltd.
66%
Toregem BioPharma
64%

OrganTech Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DJun 3, 2026
SeedFeb 10, 2023
VC RoundJun 20, 2018

OrganTech Inc. Investors

Notable investors and investment history

OrganTech Inc. investors
InvestorRounds
Iyogin Capital Company LimitedVC Round
Power AngelsSeries D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 3, 2026

    Raised $20.79M in Series D funding.

  • Jun 20, 2018

    $5.36M raised from Itochu, Iyogin Capital, and Mitsui & Co.

OrganTech Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OrganTech Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OrganTech Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTokyo
Year Founded2008
Last FundingJun 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?